cobaltous chloride has been researched along with Cirrhosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Chi, Z; Li, Q; Liu, YW; Mao, J; Min, S; Zhang, C | 1 |
| Packer, M | 1 |
| Chang, LR; Chen, JA; Chou, TM; Chu, CH; Hsu, TI; Huang, JS; Huang, PW; Jeng, SF; Jou, IM; Kuo, YL | 1 |
| Chu, S; Xu, H; Zeng, F; Zhang, M | 1 |
| Bo, H; Cao, C; Chen, W; Li, X; Liu, L; Wan, X; Yin, Z; Zhao, Y | 1 |
1 review(s) available for cobaltous chloride and Cirrhosis
| Article | Year |
|---|---|
Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics.
Topics: Basic Helix-Loop-Helix Transcription Factors; Cobalt; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Erythropoiesis; Fibrosis; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Kidney; Oxidative Stress; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
4 other study(ies) available for cobaltous chloride and Cirrhosis
| Article | Year |
|---|---|
CoCl
Topics: Bone Morphogenetic Protein 2; Cell Hypoxia; Cells, Cultured; Cobalt; Fibroblasts; Fibrosis; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Myringosclerosis; Osteogenesis; Vimentin | 2022 |
Hypoxia-induced epithelial-mesenchymal transition and fibrosis for the development of breast capsular contracture.
Topics: Animals; Breast Implants; Cell Hypoxia; Cobalt; Contracture; Epithelial-Mesenchymal Transition; Extracellular Matrix; Female; Fibronectins; Fibrosis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Implant Capsular Contracture; Matrix Metalloproteinase 9; Mice; NIH 3T3 Cells; Vimentin | 2019 |
Bevacizumab modulates the process of fibrosis in vitro.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antimutagenic Agents; Bevacizumab; Blotting, Western; Cell Hypoxia; Cells, Cultured; Cobalt; Connective Tissue Growth Factor; Cytokines; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factor 2; Fibrosis; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 2; Real-Time Polymerase Chain Reaction; Retinal Vessels; RNA, Messenger; Transforming Growth Factor beta2; Vascular Endothelial Growth Factor A | 2015 |
All-trans retinoic acid protects renal tubular epithelial cells against hypoxia induced injury in vitro.
Topics: Animals; Blotting, Western; Carboxypeptidases; Cell Hypoxia; Cell Line; Cell Survival; Cobalt; Cytoprotection; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Epithelial Cells; Fibrosis; Gene Expression Regulation; Immunoprecipitation; Kidney Tubules, Proximal; Rats; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transcription Factor RelA; Tretinoin; Vascular Endothelial Growth Factor A | 2013 |